DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Sorrento Therapeutics Amended S-3 Shows Registration For Resale Of 17.26M In Common Stock As Related To $37.8M Mar. 26, 2018-Filed Convertible Promissory Notes Offering

Benzinga · 01/23/2020 12:44